We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$9.13B
AUM Growth
-$2.03B
Cap. Flow
+$382B
Cap. Flow %
4,191.08%
Top 10 Hldgs %
16.25%
Holding
592
New
147
Increased
69
Reduced
127
Closed
192

Sector Composition

Rank Sector Weight
1 Technology 20.94%
2 Industrials 17.44%
3 Financials 11.93%
4 Healthcare 11.85%
5 Energy 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GAP
526
The Gap Inc
GAP
$7.37B
-628,000
Closed -$20.3M
NVRO
527
DELISTED
NEVRO CORP.
NVRO
-269,816
Closed -$21.5M
ALTR
528
DELISTED
Altair Engineering Inc
ALTR
-175,000
Closed -$5.98M
KA
529
DELISTED
Kineta, Inc. Common Stock
KA
-545
Closed -$213K
TCON
530
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
-500
Closed -$270K
AEL
531
DELISTED
American Equity Investment Life Holding Company
AEL
-152,004
Closed -$5.47M
SGEN
532
DELISTED
Seagen Inc. Common Stock
SGEN
-264,616
Closed -$17.6M
ACER
533
DELISTED
Acer Therapeutics Inc
ACER
-76,009
Closed -$1.64M
SYNH
534
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-444,732
Closed -$20.9M
PRTK
535
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-483,437
Closed -$4.93M
SURF
536
DELISTED
Surface Oncology, Inc. Common Stock
SURF
-180,781
Closed -$2.95M
ATTO
537
DELISTED
Atento S.A.
ATTO
-8,489
Closed -$292K
APTX
538
DELISTED
Aptinyx Inc. Common Stock
APTX
-125,000
Closed -$3.02M
NVCN
539
DELISTED
Neovasc Inc.
NVCN
-4
Closed -$5K
EVOP
540
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
-202,353
Closed -$4.16M
FSTX
541
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
-14,884
Closed -$745K
VIVE
542
DELISTED
VIVEVE MED INC
VIVE
-322
Closed -$876K
HTGM
543
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
-1,667
Closed -$978K
SWCH
544
DELISTED
Switch, Inc. Class A Common Stock
SWCH
-537,811
Closed -$6.54M
AERI
545
DELISTED
Aerie Pharmaceuticals
AERI
-84,288
Closed -$5.69M
CFMS
546
DELISTED
Conformis, Inc. Common Stock
CFMS
-23,286
Closed -$728K
EVFM
547
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
-23,695
Closed -$1.03M
ISBC
548
DELISTED
Investors Bancorp, Inc.
ISBC
-676,189
Closed -$8.65M
CSLT
549
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
-500,000
Closed -$2.13M
ADMS
550
DELISTED
Adamas Pharmaceuticals
ADMS
-39,827
Closed -$1.03M

Similar funds

Alyeska Investment Group's Q3 2018 Portfolio in Review

As of Q3 2018, Alyeska Investment Group held 592 positions worth $9.13B, down 18% from $11.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Alyeska Investment Group deployed $382B of net new capital in Q3 2018, opening 147 new positions and adding to 69 existing holdings. Its largest new stake was Marvell Technology: 6,576,490 shares worth $127M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Palo Alto Networks, an estimated $144M trimmed.

  • Alyeska Investment Group's largest Q3 2018 buy was Marvell Technology: 6,576,490 shares worth $127M.
  • Alyeska Investment Group added most to Electronic Arts in Q3 2018, an estimated $185M increase.
  • Alyeska Investment Group's biggest Q3 2018 reduction was Palo Alto Networks, cutting an estimated $144M.
  • Alyeska Investment Group fully exited Alphabet (Google) Class A in Q3 2018, selling an estimated $201M.
  • Alyeska Investment Group's ten largest holdings make up 16% of its $9.13B portfolio in Q3 2018.
  • Alyeska Investment Group opened 147 new positions and closed 192 in Q3 2018.
  • Alyeska Investment Group's portfolio value fell 18% quarter-over-quarter to $9.13B.

Based on Alyeska Investment Group's 13F filing for Q3 2018, filed 14 Nov 2018.